Actively Recruiting
The Effect of Uterine Manipulator Use During Abdominal Hysterectomy on Postoperative Sexual Function
Led by Erkan Gol · Updated on 2026-03-03
60
Participants Needed
1
Research Sites
48 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This prospective, single-center, randomized controlled trial aims to evaluate the effect of uterine manipulator use during total abdominal hysterectomy on postoperative female sexual function at 3 months, assessed by the Female Sexual Function Index (FSFI). Secondary outcomes include operative time, perioperative hemoglobin change, postoperative pain (VAS), hospital stay duration, and 30-day complications.
CONDITIONS
Official Title
The Effect of Uterine Manipulator Use During Abdominal Hysterectomy on Postoperative Sexual Function
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women aged 6518 years
- Planned total abdominal hysterectomy for benign indications
- Sexually active within the last 4 weeks
- Able to complete the Female Sexual Function Index (FSFI) questionnaire
- Provided written informed consent
You will not qualify if you...
- Gynecologic malignancy
- Major additional pelvic reconstructive surgery
- Severe psychiatric or neurologic disorder
- Inability to complete follow-up assessments
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Bakirkoy Dr. Sadi Konuk Training and Research Hospital
Istanbul, Istanbul, Turkey (Türkiye), 34147
Actively Recruiting
Research Team
E
Erkan Göl, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here